Tekla Life Sciences Investors (NYSE:HQL) on 08/17/2018 declared a dividend of $ 0.4000 per share payable on September 28, 2018 to shareholders of record as of August 28, 2018.

Tekla Life Sciences Investors (NYSE:HQL) has paid dividends since 1996, has a current dividend yield of 8.22% and has increased its dividends for 0 successive years.

Tekla Life Sciences Investors's market cap is $ 206,326,200 and has a PE ratio of 0.00. The stock price closed yesterday at $ 19.82 and has a 52 week low/high of $ 18.01 and $ 22.24.

Tekla Life Sciences Investors is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in U.S. and foreign companies in the life sciences industry. The Fund invests primarily in securities of public and private companies that are believed to have significant potential for above-average growth. As of Sep 30 2017, the Fund's investment portfolio totaled $466,979,662 and its assets totaled $468,332,479.

For more information on Tekla Life Sciences Investors click here.